Epsilon Healthcare (ASX:EPN) Gross-Profit-to-Asset % : 24.99% (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Epsilon Healthcare's annualized Gross Profit for the quarter that ended in Jun. 2023 was A$4.79 Mil. Epsilon Healthcare's average Total Assets over the quarter that ended in Jun. 2023 was A$19.16 Mil. Therefore, Epsilon Healthcare's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 24.99%.

Epsilon Healthcare Gross-Profit-to-Asset % Historical Data

The historical data trend for Epsilon Healthcare's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare Gross-Profit-to-Asset % Chart

Epsilon Healthcare Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

2.78

3.76

7.33

6.06

2.84

Epsilon Healthcare Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial								5.44	6.94	6.92	-1.44	24.99

Competitive Comparison of Epsilon Healthcare's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Epsilon Healthcare's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Epsilon Healthcare's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Epsilon Healthcare's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Epsilon Healthcare's Gross-Profit-to-Asset % falls into.

Epsilon Healthcare Gross-Profit-to-Asset % Calculation

Epsilon Healthcare's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	0.726	/	( (30.552	+	20.5)	/ 2 )
	=	0.726	/	25.526
	=	2.84 %

Epsilon Healthcare's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	4.788	/	( (20.5	+	17.819)	/ 2 )
	=	4.788	/	19.1595
	=	24.99 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Epsilon Healthcare Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Epsilon Healthcare (ASX:EPN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (ASX:EPN) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

HDRPF:USA

Address

35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000

Website

https://www.epsilonhealthcare.com.au

Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (ASX:EPN) Headlines

No Headlines